Showing 9791-9800 of 20874 results for "".
Recognizing Neuroimmune Drivers of Itch in Atopic Dermatitis and Prurigo Nodularis
https://reachmd.com/programs/dermconsult/neuroimmune-itch-atopic-dermatitis-prurigo-nodularis/51038/Disproportionate itch can signal underlying neuroimmune-driven disease in atopic dermatitis and prurigo nodularis, even when visible inflammation appears limited. To learn more about this connection, Dr. Steve Jackson speaks with Dr. Diego Dasilva. Together, they explore how neuroimmune pathways perHow Timing, Titration Speed, and Antiseizure Medication Burden Influence VNS Therapy Outcomes in Epilepsy
https://reachmd.com/programs/practical-neurology/how-timing-titration-speed-and-antiseizure-medication-burden-influence-vns-therapy-outcomes-in-epilepsy/39917/Ryan Verner, PhD, discusses findings from the large, global CORE-VNS study, including how earlier vagus nerve stimulation use and lower baseline antiseizure medication burden were associated with improved clinical response.Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
https://reachmd.com/programs/project-oncology/immune-checkpoint-inhibitors-show-promise-in-patients-with-oncogene-driver-negative-nsclc-who-have-never-smoked/33000/A multi-institutional study presented at ASCO 2025 offers critical new insights into a long-overlooked subset of non-small cell lung cancer (NSCLC) patients: never-smokers without actionable oncogenic drivers. Read about the study’s findings on the key predictors of response to immune checkpoint inhIVUS Trial
https://reachmd.com/programs/clinicians-roundtable/ivus-trial/600/Overview of the IVUS trial and resultsShared Financial Incentives for Both Physicians and Patients Improved Cholesterol Levels
https://reachmd.com/programs/the-jama-report/shared-financial-incentives-both-physicians-and-patients-improved-cholesterol-levels/7744/[Read the Article] Financial incentives for physicians or patients are one way healthcare organizations are trying to improve health outcomes. A new study examined whether providing these financial incentives would help improve low-density lipoprotein cholesterol (LDL-C) in patients with a high-riskPrimary Biliary Cholangitis Pathophysiology: From Genetic Risk to Immune Dysregulation
https://reachmd.com/programs/gi-insights/primary-biliary-cholangitis-pathophysiology-from-genetic-risk-to-immune-dysregulation/29159/Tune in to find out how genetic and environmental triggers can cause immune dysregulation in primary biliary cholangitis.Informed Consent
https://reachmd.com/programs/clinicians-roundtable/informed-consent-1/844/Dr. Michael Greenberg welcomes Dr. James Gottesman as he discusses how using a computer generated consent and information forms can help reduce physician stress.Informed Consent
https://reachmd.com/programs/clinicians-roundtable/informed-consent/843/In this segment, Dr. Michael Greenberg speaks with Dr. James Gottesman about how a more extensive informed consent can save doctors time and moneyPain and Physical Function Improve after Weight-Loss Surgery
https://reachmd.com/programs/the-jama-report/pain-and-physical-function-improve-after-weight-loss-surgery/8051/Among a group of patients with severe obesity who underwent bariatric surgery, a large percentage experienced improvement in pain.Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
https://reachmd.com/programs/living-rheum/exploring-cadherin-6-a-key-driver-of-inflammation-in-rheumatoid-arthritis/32794/Despite advances in biologics, many patients with rheumatoid arthritis still experience persistent inflammation. However, cadherin-6 has recently been identified as a potential treatment target. Hear from Dr. Gary Firestein as he explains the discovery, function, and therapeutic potential of cadheri